Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls
Clinical Endocrinology Oct 20, 2017
                Huddleston HG, et al. - To compare age-associated changes in cardiovascular risk markers in lean and obese reproductive-aged women with polycystic ovary syndrome (PCOS) with community controls. According to the outcome obtained, reproductive-aged women with PCOS demonstrated declines in biochemical hyperandrogenaemia over time. Despite this, PCOS subjects experienced steeper increases in cardiovascular risk factors related to insulin resistance, including triglycerides and HOMA-IR.
            
              Go to Original
            
            Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
- 
    
Exclusive Write-ups & Webinars by KOLs
 - 
    Daily Quiz by specialty
 - 
    Paid Market Research Surveys
 - 
    Case discussions, News & Journals' summaries